Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Podocyte loss involves MDM2-driven mitotic catastrophe.

Mulay SR, Thomasova D, Ryu M, Kulkarni OP, Migliorini A, Bruns H, Gröbmayr R, Lazzeri E, Lasagni L, Liapis H, Romagnani P, Anders HJ.

J Pathol. 2013 Jul;230(3):322-35. doi: 10.1002/path.4193.

PMID:
23749457
2.

The antiviral cytokines IFN-α and IFN-β modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration.

Migliorini A, Angelotti ML, Mulay SR, Kulkarni OO, Demleitner J, Dietrich A, Sagrinati C, Ballerini L, Peired A, Shankland SJ, Liapis H, Romagnani P, Anders HJ.

Am J Pathol. 2013 Aug;183(2):431-40. doi: 10.1016/j.ajpath.2013.04.017.

PMID:
23747509
3.

Murine Double Minute-2 Prevents p53-Overactivation-Related Cell Death (Podoptosis) of Podocytes.

Thomasova D, Bruns HA, Kretschmer V, Ebrahim M, Romoli S, Liapis H, Kotb AM, Endlich N, Anders HJ.

J Am Soc Nephrol. 2015 Jul;26(7):1513-23. doi: 10.1681/ASN.2014040345.

4.

Fn14 in podocytes and proteinuric kidney disease.

Sanchez-Niño MD, Poveda J, Sanz AB, Mezzano S, Carrasco S, Fernandez-Fernandez B, Burkly LC, Nair V, Kretzler M, Hodgin JB, Ruiz-Ortega M, Selgas R, Egido J, Ortiz A.

Biochim Biophys Acta. 2013 Dec;1832(12):2232-43. doi: 10.1016/j.bbadis.2013.08.010.

5.

Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.

Dai C, Saleem MA, Holzman LB, Mathieson P, Liu Y.

Kidney Int. 2010 Jun;77(11):962-73. doi: 10.1038/ki.2010.40.

6.

Inhibition of p53-murine double minute 2 interaction by nutlin-3A stabilizes p53 and induces cell cycle arrest and apoptosis in Hodgkin lymphoma.

Drakos E, Thomaides A, Medeiros LJ, Li J, Leventaki V, Konopleva M, Andreeff M, Rassidakis GZ.

Clin Cancer Res. 2007 Jun 1;13(11):3380-7.

7.

Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo.

Logar CM, Brinkkoetter PT, Krofft RD, Pippin JW, Shankland SJ.

Kidney Int. 2007 Aug;72(4):489-98.

8.

Podocyte mitosis - a catastrophe.

Lasagni L, Lazzeri E, Shankland SJ, Anders HJ, Romagnani P.

Curr Mol Med. 2013 Jan;13(1):13-23. Review.

9.

MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice.

Mulay SR, Thomasova D, Ryu M, Anders HJ.

Kidney Int. 2012 Jun;81(12):1199-211. doi: 10.1038/ki.2011.482.

10.

Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.

Wu JB, Ye SF, Liang CL, Li YC, Yu YJ, Lai JM, Lin H, Zheng J, Zhou JY.

J Ethnopharmacol. 2014 Feb 12;151(3):1124-32. doi: 10.1016/j.jep.2013.12.028.

PMID:
24389029
11.

c-Abl mediates angiotensin II-induced apoptosis in podocytes.

Chen X, Ren Z, Liang W, Zha D, Liu Y, Chen C, Singhal PC, Ding G.

J Mol Histol. 2013 Oct;44(5):597-608. doi: 10.1007/s10735-013-9505-8.

12.

Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).

Drakos E, Singh RR, Rassidakis GZ, Schlette E, Li J, Claret FX, Ford RJ Jr, Vega F, Medeiros LJ.

Leukemia. 2011 May;25(5):856-67. doi: 10.1038/leu.2011.28.

13.

Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders.

Lasagni L, Ballerini L, Angelotti ML, Parente E, Sagrinati C, Mazzinghi B, Peired A, Ronconi E, Becherucci F, Bani D, Gacci M, Carini M, Lazzeri E, Romagnani P.

Stem Cells. 2010 Sep;28(9):1674-85. doi: 10.1002/stem.492.

14.

CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.

Marshall CB, Krofft RD, Pippin JW, Shankland SJ.

Am J Physiol Renal Physiol. 2010 May;298(5):F1140-51. doi: 10.1152/ajprenal.00216.2009.

15.

Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells.

Rigatti MJ, Verma R, Belinsky GS, Rosenberg DW, Giardina C.

Mol Carcinog. 2012 May;51(5):363-78. doi: 10.1002/mc.20795.

16.

Distinct roles for basal and induced COX-2 in podocyte injury.

Cheng H, Fan X, Guan Y, Moeckel GW, Zent R, Harris RC.

J Am Soc Nephrol. 2009 Sep;20(9):1953-62. doi: 10.1681/ASN.2009010039.

17.

New insights into the pathology of podocyte loss: mitotic catastrophe.

Liapis H, Romagnani P, Anders HJ.

Am J Pathol. 2013 Nov;183(5):1364-74. doi: 10.1016/j.ajpath.2013.06.033. Review.

18.

MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy.

Kojima K, Konopleva M, Samudio IJ, Shikami M, Cabreira-Hansen M, McQueen T, Ruvolo V, Tsao T, Zeng Z, Vassilev LT, Andreeff M.

Blood. 2005 Nov 1;106(9):3150-9.

19.

Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.

Ambrosini G, Sambol EB, Carvajal D, Vassilev LT, Singer S, Schwartz GK.

Oncogene. 2007 May 24;26(24):3473-81.

PMID:
17146434
20.

Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy.

Sun YB, Qu X, Zhang X, Caruana G, Bertram JF, Li J.

PLoS One. 2013;8(1):e55027. doi: 10.1371/journal.pone.0055027.

Items per page

Supplemental Content

Support Center